Advertisement

Gestational Trophoblastic Tumors and Related Tumor-Like Lesions

  • Ie-Ming Shih
  • Michael T. Mazur
  • Robert J. Kurman

Abstract

Gestational trophoblastic disease (GTD) encompasses a heterogeneous group of lesions with specific clinical features, morphological characteristics, and pathogenesis. The World Health Organization classification of GTD includes complete and partial hydatidiform mole, invasive mole, choriocarcinoma, placental site trophoblastic tumor (PSTT), epithelioid trophoblastic tumor, exaggerated placental site, and placental site nodule (Table 20.1 ) [145]. Some of these lesions are true neoplasms, whereas others represent abnormally formed placentas with a predisposition for neoplastic transformation of the trophoblast. Two benign entities, the exaggerated placental site and the placental site nodule, are included because they are trophoblastic lesions that must be distinguished from other entities with malignant potential. The literature on GTD is extensive and at times confusing because of inconsistencies in classification and terminology. In fact, the necessity of a morphologic classification has been questioned, because current management is largely medical and in the case of trophoblastic disease following a mole, treatment is often conducted in the absence of a histological diagnosis. Thus, all trophoblastic lesions are frequently combined under the rubric of GTD without applying specific pathological terms. However, recent studies demonstrate profound differences in the etiology, morphology, and clinical behavior of various forms of the disease. These studies underscore the importance of a uniform histological classification to facilitate standardized reporting of data and to ensure appropriate clinical management. Nonetheless, the term GTD has clinical utility, as the principles of human chorionic gonadotropin (hCG) monitoring in follow-up and the chemotherapy of metastatic or persistent disease are similar for all these entities.

Keywords

Trophoblastic Cell Implantation Site Hydatidiform Mole Gestational Trophoblastic Disease Molar Pregnancy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Akbulut M, Tosun H, Soysal ME, Oztekin O (2008) Endometrioid carcinoma of the endometrium with choriocarcinomatous differentiation: a case report and review of the literature. Arch Gynecol Obstet 278:79–84PubMedCrossRefGoogle Scholar
  2. 2.
    Allan RW, Algood CB, Shih Ie M (2009) Metastatic epithelioid trophoblastic tumor in a male patient with mixed germ-cell tumor of the testis. Am J Surg Pathol 33:1902–1905PubMedCrossRefGoogle Scholar
  3. 3.
    Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C (2003) Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 4:670–678PubMedCrossRefGoogle Scholar
  4. 4.
    Ariel I, Boldes R, Weintraub A, Reinus C, Beller U, Arbel R (2009) Chorangiocarcinoma: a case report and review of the literature. Int J Gynecol Pathol 28:267–271PubMedCrossRefGoogle Scholar
  5. 5.
    Arroyo MR, Podda A, Cao D, Rodriguez MM (2008) Placental site trophoblastic tumor in the ovary of a young child with isosexual precocious puberty. Pediatr Dev Pathol 12:73–76CrossRefGoogle Scholar
  6. 6.
    Azuma C, Saji F, Nobunaga T, Kamiura S, Kimura T, Tokugawa Y, Koyama M, Tanizawa O (1990) Studies on the pathogenesis of choriocarcinoma by analysis of restriction fragment length polymorphisms. Cancer Res 50:488–491PubMedGoogle Scholar
  7. 7.
    Baergen RN, Rutgers J, Young RH (2003) Extrauterine lesions of intermediate trophoblast. Int J Gynecol Pathol 22:362–367PubMedCrossRefGoogle Scholar
  8. 8.
    Baergen RN, Rutgers JL, Young RH, Osann K, Scully RE (2006) Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol 100:511–520PubMedCrossRefGoogle Scholar
  9. 9.
    Bagshawe KD, Lawler SD, Paradinas FJ, Dent J, Brown P, Boxer GM (1990) Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole. Lancet 335:1074–1076PubMedCrossRefGoogle Scholar
  10. 10.
    Behtash N, Ghaemmaghami F, Hasanzadeh M (2005) Long term remission of metastatic placental site trophoblastic tumor (PSTT): case report and review of literature. World J Surg Oncol 3:34PubMedCrossRefGoogle Scholar
  11. 11.
    Berkowitz RS, Im SS, Bernstein MR, Goldstein DP (1998) Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med 43:81–86PubMedGoogle Scholar
  12. 12.
    Berkowitz LW, Lage JM (1990) Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol 36:358–362PubMedCrossRefGoogle Scholar
  13. 13.
    Bifulco C, Johnson C, Hao L, Kermalli H, Bell S, Hui P (2008) Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis. Am J Surg Pathol 32:445–451PubMedCrossRefGoogle Scholar
  14. 14.
    Brewer CA, Adelson MD, Elder RC (1992) Erythrocytosis associated with a placental-site trophoblastic tumor. Obstet Gynecol 79:846–849PubMedGoogle Scholar
  15. 15.
    Burrows TD, King A, Loke YW (1994) Expression of adhesion molecules by endovascular trophoblast and decidual endothelial cells: implications for vascular invasion during implantation. Placenta 15:21–33PubMedCrossRefGoogle Scholar
  16. 16.
    Carinelli SG, Verdola N, Zanotti F (1989) Placental site nodule: a report of 17 cases. Pathol Res Pract 185:30–34Google Scholar
  17. 17.
    Castrillon DH, Sun D, Weremowicz S, Fisher RA, Crum CP, Genest DR (2001) Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol 25:1225–1230PubMedCrossRefGoogle Scholar
  18. 18.
    Chang YL, Chang TC, Hsueh S, Huang KG, Wang PN, Liu HP, Soong YK (1999) Prognostic factors and treatment for placental site trophoblastic tumor: report of 3 cases and analysis of 88 cases. Gynecol Oncol 73:216–222PubMedCrossRefGoogle Scholar
  19. 19.
    Cheung AN, Shen DH, Khoo US, Wong LC, Ngan HY (1998) p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression. J Clin Pathol 51:159–162PubMedCrossRefGoogle Scholar
  20. 20.
    Chew SH, Perlman EJ, Williams R, Kurman RJ, Ronnett BM (2000) Morphology and DNA content analysis in the evaluation of first trimester placentas for partial hydatidiform mole (PHM). Hum Pathol 31:914–924PubMedCrossRefGoogle Scholar
  21. 21.
    Chilosi M, Piazzola E, Lestani M, Benedetti A, Guasparri I, Granchelli G, Aldovini D, Leonardi E, Pizzolo G, Doglioni C et al (1998) Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest 78:269–276PubMedGoogle Scholar
  22. 22.
    Cole LA (1998) hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease. J Reprod Med 43:3–10PubMedGoogle Scholar
  23. 23.
    Cole LA (2009) New discoveries on the biology and detection of human chorionic gonadotropin. Reprod Biol Endocrinol 7:8PubMedCrossRefGoogle Scholar
  24. 24.
    Cole ME, Broaddus R, Thaker P, Landen C, Freedman RS (2008) Placental-site trophoblastic tumors: a case of resistant pulmonary metastasis. Nat Clin Pract Oncol 5:171–175PubMedCrossRefGoogle Scholar
  25. 25.
    Cole LA, Khanlian SA, Muller CY, Giddings A, Kohorn E, Berkowitz R (2006) Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol 102:160–164PubMedCrossRefGoogle Scholar
  26. 26.
    Coukos G, Makrigiannakis A, Chung J, Randall TC, Rubin SC, Benjamin I (1999) Complete hydatidiform mole. A disease with a changing profile [In Process Citation]. J Reprod Med 44:698–704PubMedGoogle Scholar
  27. 27.
    Coulson LE, Kong CS, Zaloudek C (2000) Epithelioid trophoblastic tumor of the uterus in a postmenopausal woman: a case report and review of the literature. Am J Surg Pathol 24:1558–1562PubMedCrossRefGoogle Scholar
  28. 28.
    Czernobilsky B, Barash A, Lancet M (1982) Partial moles: a clinicopathologic study of 25 cases. Obstet Gynecol 59:75–77PubMedGoogle Scholar
  29. 29.
    Datta T, Banerjee AK, Adeyemo AK, McCullough WL, Duncan A (2007) Intraplacental choriocarcinoma associated with pregnancy continuum: a diagnostic dilemma. J Obstet Gynaecol 27:731–732PubMedCrossRefGoogle Scholar
  30. 30.
    Denny LA, Dehaeck K, Nevin J, Soeters R, van Wijk AL, Megevand E, Bloch B (1995) Placental site trophoblastic tumor: three case reports and literature review. Gynecol Oncol 59:300–303PubMedCrossRefGoogle Scholar
  31. 31.
    Dotto J, Hui P (2008) Lack of genetic association between exaggerated placental site reaction and placental site trophoblastic tumor. Int J Gynecol Pathol 27:562–567PubMedCrossRefGoogle Scholar
  32. 32.
    Eckstein RP, Paradinas FJ, Bagshawe KD (1982) Placental site trophoblastic tumour (trophoblastic pseudotumour): a study of four cases requiring hysterectomy including one fatal case. Histopathology 6:211–226PubMedCrossRefGoogle Scholar
  33. 33.
    Elston C (1995) Gestational trophoblastic disease, 4th edn. New York, Churchill LinvingstoneGoogle Scholar
  34. 34.
    Fadare O, Parkash V, Carcangiu ML, Hui P (2006) Epithelioid trophoblastic tumor: clinicopathological features with an emphasis on uterine cervical involvement. Mod Pathol 19:75–82PubMedCrossRefGoogle Scholar
  35. 35.
    Feltmate CM, Genest DR, Goldstein DP, Berkowitz RS (2002) Advances in the understanding of placental site trophoblastic tumor. J Reprod Med 47:337–341PubMedGoogle Scholar
  36. 36.
    Fisher RA, Paradinas FJ, Newlands ES, Boxer GM (1992) Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus. Br J Cancer 65:355–358PubMedCrossRefGoogle Scholar
  37. 37.
    Folberg R, Hendrix MJ, Maniotis AJ (2000) Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156:361–381PubMedCrossRefGoogle Scholar
  38. 38.
    Fox H, Laurini RN (1988) Intraplacental choriocarcinoma: a report of two cases. J Clin Pathol 41:1085–1088PubMedCrossRefGoogle Scholar
  39. 39.
    Fraser GC, Blair GK, Hemming A, Murphy JJ, Rogers P (1992) The treatment of simultaneous choriocarcinoma in mother and baby. J Pediatr Surg 27:1318–1319PubMedCrossRefGoogle Scholar
  40. 40.
    Fukunaga M, Ushigome S (1993) Malignant trophoblastic tumors: immunohistochemical and flow cytometric comparison of choriocarcinoma and placental site trophoblastic tumors. Hum Pathol 24:1098–1106PubMedCrossRefGoogle Scholar
  41. 41.
    Fukunaga M, Ushigome S (1993) Metastasizing placental site trophoblastic tumor. An immunohistochemical and flow cytometric study of two cases. Am J Surg Pathol 17:1003–1010PubMedCrossRefGoogle Scholar
  42. 42.
    Garg R, Russell J, Shih I-M, Bristow RE (2004) Have you ruled out a placental site nodule? Contempory Obst Gyn 49:18–20Google Scholar
  43. 43.
    Garner EI, Goldstein DP, Feltmate CM, Berkowitz RS (2007) Gestational trophoblastic disease. Clin Obstet Gynecol 50:112–122PubMedCrossRefGoogle Scholar
  44. 44.
    Genest DR (2001) Partial hydatidiform mole: clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis. Int J Gynecol Pathol 20:315–322PubMedCrossRefGoogle Scholar
  45. 45.
    Golfier F, Raudrant D, Frappart L, Mathian B, Guastalla JP, Trillet-Lenoir V, Vaudoyer F, Hajri T, Schott AM (2007) First epidemiological data from the French Trophoblastic Disease Reference Center. Am J Obstet Gynecol 196(172):e171–e175Google Scholar
  46. 46.
    Golubovsky MD (2003) Postzygotic diploidization of triploids as a source of unusual cases of mosaicism, chimerism and twinning. Hum Reprod 18:236–242PubMedCrossRefGoogle Scholar
  47. 47.
    Goto S, Yamada A, Ishizuka T, Tomoda Y (1993) Development of postmolar trophoblastic disease after partial molar pregnancy. Gynecol Oncol 48:165–170PubMedCrossRefGoogle Scholar
  48. 48.
    Guschmann M, Schulz-Bischof K, Vogel M (2003) Incidental chorangiocarcinoma. Case report, immunohistochemistry and theories of possible histogenesis. Pathologe 24:124–127PubMedGoogle Scholar
  49. 49.
    Hamazaki S, Nakamoto S, Okino T, Tsukayama C, Mori M, Taguchi K, Okada S (1999) Epithelioid trophoblastic tumor: morphological and immunohistochemical study of three lung lesions. Hum Pathol 30:1321–1327PubMedCrossRefGoogle Scholar
  50. 50.
    Hancock BW, Nazir K, Everard JE (2006) Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome. J Reprod Med 51:764–766PubMedGoogle Scholar
  51. 51.
    Hando T, Ohno M, Kurose T (1998) Recent aspects of gestational trophoblastic disease in Japan. Int J Gynaecol Obstet 60(Suppl 1):S71–S76PubMedCrossRefGoogle Scholar
  52. 52.
    Harvey RA, Pursglove HD, Schmid P, Savage PM, Mitchell HD, Seckl MJ (2008) Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors. J Reprod Med 53:643–648PubMedGoogle Scholar
  53. 53.
    Hassadia A, Gillespie A, Tidy J, Everard RGNJ, Wells M, Coleman R, Hancock B (2005) Placental site trophoblastic tumour: clinical features and management. Gynecol Oncol 99:603–607PubMedCrossRefGoogle Scholar
  54. 54.
    Hernandez L, Kozlov S, Piras G, Stewart CL (2003) Paternal and maternal genomes confer opposite effects on proliferation, cell-cycle length, senescence, and tumor formation. Proc Natl Acad Sci USA 100:13344–13349PubMedCrossRefGoogle Scholar
  55. 55.
    Hertig AT (1956) Tumors of the female sex organs. Part 1. Hydatidifrom mole and choriocarcinoma. In: Atlas of tumor pathology, section 9, fascicle 33. Armed Forces Institute of Pathology, Washington DCGoogle Scholar
  56. 56.
    Hoekstra AV, Keh P, Lurain JR (2004) Placental site trophoblastic tumor: a review of 7 cases and their implications for prognosis and treatment. J Reprod Med 49:447–452PubMedGoogle Scholar
  57. 57.
    Houghton O, McCluggage WG (2009) The expression and diagnostic utility of p63 in the female genital tract. Adv Anat Pathol 16:316–321PubMedCrossRefGoogle Scholar
  58. 58.
    How J, Scurry J, Grant P, Sapountzis K, Ostor A, Fortune D, Armes J (1995) Placental site trophoblastic tumor. Report of three cases and review of the literature. Int J Gynecol Cancer 5:241–249PubMedCrossRefGoogle Scholar
  59. 59.
    Hsieh TY, Hsu KF, Kuo PL, Huang SC (2008) Uterine choriocarcinoma accompanied by an extremely high human chorionic gonadotropin level and thyrotoxicosis. J Obstet Gynaecol Res 34:274–278PubMedCrossRefGoogle Scholar
  60. 60.
    Huettner PC, Gersell DJ (1994) Placental site nodule: a clinicopathologic study of 38 cases. Int J Gynecol Pathol 13:191–198PubMedCrossRefGoogle Scholar
  61. 61.
    Hui P, Parkash V, Perkins AS, Carcangiu ML (2000) Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome. Lab Invest 80:965–972PubMedCrossRefGoogle Scholar
  62. 62.
    Hui P, Riba A, Pejovic T, Johnson T, Baergen RN, Ward D (2004) Comparative genomic hybridization study of placental site trophoblastic tumour: a report of four cases. Mod Pathol 17:248–251PubMedCrossRefGoogle Scholar
  63. 63.
    Ilancheran A (1998) Optimal treatment in gestational trophoblastic disease. Ann Acad Med Singapore 27:698–704PubMedGoogle Scholar
  64. 64.
    Ino K, Suzuki T, Uehara C, Nagasaka T, Okamoto T, Kikkawa F, Mizutani S (2000) The expression and localization of neutral endopeptidase 24.11/CD10 in human gestational trophoblastic diseases. Lab Invest 80:1729–1738PubMedCrossRefGoogle Scholar
  65. 65.
    Jacobs PA, Hunt PA, Matsuura JS, Wilson CC, Szulman AE (1982) Complete and partial hydatidiform mole in Hawaii: cytogenetics, morphology and epidemiology. Br J Obstet Gynaecol 89:258–266PubMedCrossRefGoogle Scholar
  66. 66.
    Jacques SM, Qureshi F, Ramirez NC, Lawrence WD (1997) Retained trophoblastic tissue in fallopian tubes: a consequence of unsuspected ectopic pregnancies. Int J Gynecol Pathol 16:219–224PubMedCrossRefGoogle Scholar
  67. 67.
    Janni W, Hantschmann P, Rehbock J, Braun S, Lochmueller E, Kindermann G (1999) Successful treatment of malignant placental site trophoblastic tumor with combined cytostatic-surgical approach: case report and review of literature. Gynecol Oncol 75:164–169PubMedCrossRefGoogle Scholar
  68. 68.
    Jauniaux E (1999) Partial moles: from postnatal to prenatal diagnosis. Placenta 20:379–388PubMedCrossRefGoogle Scholar
  69. 69.
    Jauniaux E, Zucker M, Meuris S, Verhest A, Wilkin P, Hustin J (1988) Chorangiocarcinoma: an unusual tumour of the placenta. The missing link? Placenta 9:607–613PubMedCrossRefGoogle Scholar
  70. 70.
    Jones WB, Romain K, Erlandson RA, Burt ME, Lewis JL Jr (1993) Thoracotomy in the management of gestational choriocarcinoma. A clinicopathologic study. Cancer 72:2175–2181PubMedCrossRefGoogle Scholar
  71. 71.
    Kalhor N, Ramirez PT, Deavers MT, Malpica A, Silva EG (2009) Immunohistochemical studies of trophoblastic tumors. Am J Surg Pathol 33:633–638PubMedCrossRefGoogle Scholar
  72. 72.
    Keep D, Zaragoza MV, Hassold T, Redline RW (1996) Very early complete hydatidiform mole. Hum Pathol 27:708–713PubMedCrossRefGoogle Scholar
  73. 73.
    Khong TY (2000) Chorangioma with trophoblastic proliferation. Virchows Arch 436:167–171PubMedCrossRefGoogle Scholar
  74. 74.
    Kim SY, Chang AS, Ratts VS (2005) Radiographic and hysteroscopic findings of a placental site nodule. Fertil Steril 83:213–215PubMedCrossRefGoogle Scholar
  75. 75.
    Kim MJ, Kim KR, Ro JY, Lage JM, Lee HI (2006) Diagnostic and pathogenetic significance of increased stromal apoptosis and incomplete vasculogenesis in complete hydatidiform moles in very early pregnancy periods. Am J Surg Pathol 30:362–369PubMedGoogle Scholar
  76. 76.
    Kim JH, Park DC, Bae SN, Namkoong SE, Kim SJ (1998) Subsequent reproductive experience after treatment for gestational trophoblastic disease. Gynecol Oncol 71:108–112PubMedCrossRefGoogle Scholar
  77. 77.
    Kodama S, Kase H, Aoki Y, Yahata T, Tanaka K, Motoyama T, Dewa K (1996) Recurrent placental site trophoblastic tumor of the uterus: clinical, pathologic, ultrastructural, and DNA fingerprint study. Gynecol Oncol 60:89–93PubMedCrossRefGoogle Scholar
  78. 78.
    Kuo K-T, Chen M-J, Lin M-C (2004) Epithelioid trophoblastic tumor of the broad ligament. Am J Surg Pathol 28:405–409PubMedCrossRefGoogle Scholar
  79. 79.
    Kurman RJ (1991) The morphology, biology, and pathology of intermediate trophoblast: a look back to the present. Hum Pathol 22:847–855PubMedCrossRefGoogle Scholar
  80. 80.
    Kurman RJ, Scully RE, Norris HJ (1976) Trophoblastic pseudotumor of the uterus: an exaggerated form of “syncytial endometritis” simulating a malignant tumor. Cancer 38:1214–1226PubMedCrossRefGoogle Scholar
  81. 81.
    Kurman RJ, Young RH, Norris HJ, Main CS, Lawrence WD, Scully RE (1984) Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. Int J Gynecol Pathol 3:101–121PubMedCrossRefGoogle Scholar
  82. 82.
    Lage JM, Mark SD, Roberts DJ, Goldstein DP, Bernstein MR, Berkowitz RS (1992) A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol 79:403–410PubMedCrossRefGoogle Scholar
  83. 83.
    Lathrop JC, Lauchlan S, Nayak R, Ambler M (1988) Clinical characteristics of placental site trophoblastic tumor (PSTT). Gynecol Oncol 31:32–42PubMedCrossRefGoogle Scholar
  84. 84.
    Lee Y, Kim KR, McKeon F, Yang A, Boyd TK, Crum CP, Parast MM (2007) A unifying concept of trophoblastic differentiation and malignancy defined by biomarker expression. Hum Pathol 38:1003–1013PubMedCrossRefGoogle Scholar
  85. 85.
    Leiserowitz GS, Webb MJ (1996) Treatment of placental site trophoblastic tumor with hysterotomy and uterine reconstruction. Obstet Gynecol 88:696–699PubMedCrossRefGoogle Scholar
  86. 86.
    Lewin SN, Aghajanian C, Moreira AL, Soslow RA (2009) Extrauterine epithelioid trophoblastic tumors presenting as primary lung carcinomas: morphologic and immunohistochemical features to resolve a diagnostic dilemma. Am J Surg Pathol 33:1809–1814PubMedCrossRefGoogle Scholar
  87. 87.
    Li J, Shi Y, Wan X, Qian H, Zhou C, Chen X (2010) Epithelioid trophoblastic tumor: a clinicopathological and immunohistochemical study of seven cases. Med Oncol (in press)Google Scholar
  88. 88.
    Li HW, Tsao SW, Cheung AN (2002) Current understandings of the molecular genetics of gestational trophoblastic diseases. Placenta 23:20–31PubMedCrossRefGoogle Scholar
  89. 89.
    Lipata F, Parkash V, Talmor M, Bell S, Chen S, Maric V, Hui P (2010) Precise DNA genotyping diagnosis of hydatidiform mole. Obstet Gynecol 115:784–794PubMedCrossRefGoogle Scholar
  90. 90.
    Macdonald MC, Palmer JE, Hancock BW, Tidy JA (2008) Diagnostic challenges in extrauterine epithelioid trophoblastic tumours: a report of two cases. Gynecol Oncol 108:452–454PubMedCrossRefGoogle Scholar
  91. 91.
    Machtinger R, Gotlieb WH, Korach J, Fridman E, Apter S, Goldenberg M, Ben-Baruch G (2005) Placental site trophoblastic tumor: outcome of five cases including fertility preserving management. Gynecol Oncol 96:56–61PubMedCrossRefGoogle Scholar
  92. 92.
    Mao TL, Kurman RJ, Huang CC, Lin MC, Shih I-M (2007) Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol 31:1726–1732PubMedCrossRefGoogle Scholar
  93. 93.
    Mao TL, Kurman RJ, Jeng YM, Huang W, Shih I-M (2008) HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Am J Surg Pathol 32:236–242PubMedCrossRefGoogle Scholar
  94. 94.
    Mao TL, Seidman JD, Kurman RJ, Shih I-M (2006) Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor–an aid in differential diagnosis. Am J Surg Pathol 30:1105–1110PubMedCrossRefGoogle Scholar
  95. 95.
    Matsui H, Iizuka Y, Sekiya S (1996) Incidence of invasive mole and choriocarcinoma following partial hydatidiform mole. Int J Gynaecol Obstet 53:63–64PubMedCrossRefGoogle Scholar
  96. 96.
    Mazur MT (1989) Metastatic gestational choriocarcinoma. Unusual pathologic variant following therapy. Cancer 63:1370–1377PubMedCrossRefGoogle Scholar
  97. 97.
    McConnell TG, Murphy KM, Hafez M, Vang R, Ronnett B (2009) Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. Am J Surg Pathol 33:805–817PubMedCrossRefGoogle Scholar
  98. 98.
    McConnell TG, Norris-Kirby A, Hagenkord JM, Ronnett BM, Murphy KM (2009) Complete hydatidiform mole with retained maternal chromosomes 6 and 11. Am J Surg Pathol 33:1409–1415PubMedCrossRefGoogle Scholar
  99. 99.
    Medeiros F, Callahan MJ, Elvin JA, Dorfman DM, Berkowitz RS, Quade BJ (2008) Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole. Int J Gynecol Pathol 27:247–251PubMedGoogle Scholar
  100. 100.
    Menczer J, Girtler O, Zajdel L, Glezerman M (1999) Metastatic trophoblastic disease following partial hydatidiform mole: case report and literature review. Gynecol Oncol 74:304–307PubMedCrossRefGoogle Scholar
  101. 101.
    Meydanli MM, Kucukali T, Usubutun A, Ataoglu O, Kafkasli A (2002) Epithelioid trophoblastic tumor of the endocervix: a case report. Gynecol Oncol 87:219–224PubMedCrossRefGoogle Scholar
  102. 102.
    Mi S, Lee X, Li X-P, Veldman GM, Finnerty H, Racie L, LaVallie E, Tang X-Y, Edouard P, Howes S et al (2000) Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403:785–789PubMedCrossRefGoogle Scholar
  103. 103.
    Milingos D, Doumplis D, Savage P, Seckl M, Lindsay I, Smith JR (2007) Placental site trophoblastic tumor with an ovarian metastasis. Int J Gynecol Cancer 17:925–927PubMedCrossRefGoogle Scholar
  104. 104.
    Montes M, Roberts D, Berkowitz RS, Genest DR (1996) Prevalence and significance of implantation site trophoblastic atypia in hydatidiform moles and spontaneous abortions. Am J Clin Pathol 105:411–416PubMedGoogle Scholar
  105. 105.
    Moore-Maxwell CA, Robboy SJ (2004) Placental site trophoblastic tumor arising from antecedent molar pregnancy. Gynecol Oncol 92:708–712PubMedCrossRefGoogle Scholar
  106. 106.
    Morgan JM, Lurain JR (2008) Gestational trophoblastic neoplasia: an update. Curr Oncol Rep 10:497–504PubMedCrossRefGoogle Scholar
  107. 107.
    Mosher R, Goldstein DP, Berkowitz R, Bernstein M, Genest DR (1998) Complete hydatidiform mole. Comparison of clinicopathologic features, current and past. J Reprod Med 43:21–27PubMedGoogle Scholar
  108. 108.
    Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R, Bagga R, Kircheisen R, Ao A, Ratti B et al (2006) Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet 38:300–302PubMedCrossRefGoogle Scholar
  109. 109.
    Nagai Y, Kamoi S, Matsuoka T, Hata A, Jobo T, Ogasawara T, Aoki Y, Ohira S, Okamoto T, Nakamoto T et al (2007) Impact of p53 immunostaining in predicting advanced or recurrent placental site trophoblastic tumors: a study of 12 cases. Gynecol Oncol 106:446–452PubMedCrossRefGoogle Scholar
  110. 110.
    Narita F, Takeuchi K, Hamana S, Ohbayashi C, Ayata M, Maruo T (2003) Epithelioid trophoblastic tumor (ETT) initially interpreted as cervical cancer. Int J Gynecol Cancer 13:551–554PubMedCrossRefGoogle Scholar
  111. 111.
    Nayar R, Snell J, Silverberg SG, Lage JM (1996) Placental site nodule occurring in a fallopian tube. Hum Pathol 27:1243–1245PubMedCrossRefGoogle Scholar
  112. 112.
    Newlands ES, Bower M, Fisher RA, Paradinas FJ (1998) Management of placental site trophoblastic tumors. J Reprod Med 43:53–59PubMedGoogle Scholar
  113. 113.
    Newlands ES, Mulholland PJ, Holden L, Seckl MJ, Rustin GJ (2000) Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 18:854–859PubMedGoogle Scholar
  114. 114.
    Ngan S, Seckl MJ (2007) Gestational trophoblastic neoplasia management: an update. Curr Opin Oncol 19:486–491PubMedCrossRefGoogle Scholar
  115. 115.
    Niemann I, Hansen ES, Sunde L (2007) The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy. Gynecol Oncol 104:411–415PubMedCrossRefGoogle Scholar
  116. 116.
    Noh HT, Lee KH, Lee MA, Ko YB, Hwang SH, Son SK (2008) Epithelioid trophoblastic tumor of paracervix and parametrium. Int J Gynecol Cancer 18:843–846PubMedCrossRefGoogle Scholar
  117. 117.
    Nugent D, Hassadia A, Everard J, Hancock BW, Tidy JA (2006) Postpartum choriocarcinoma presentation, management and survival. J Reprod Med 51:819–824PubMedGoogle Scholar
  118. 118.
    Numnum TM, Kilgore LC, Conner MG, Straughn JM Jr (2006) Fertility sparing therapy in a patient with placental site trophoblastic tumor: a case report. Gynecol Oncol 103:1141–1143PubMedCrossRefGoogle Scholar
  119. 119.
    Ohira S, Yamazaki T, Hatano H, Harada O, Toki T, Konishi I (2000) Epithelioid trophoblastic tumor metastatic to the vagina: an immunohistochemical and ultrastructural study. Int J Gynecol Pathol 19:381–386PubMedCrossRefGoogle Scholar
  120. 120.
    Oldt RJ 3rd, Kurman RJ, Shih I-M (2002) Molecular genetic analysis of placental site trophoblastic tumors and epithelioid trophoblastic tumors confirms their trophoblastic origin. Am J Pathol 161:1033–1037PubMedCrossRefGoogle Scholar
  121. 121.
    Olsen JH, Mellemkjaer L, Gridley G, Brinton L, Johansen C, Kjaer SK (1999) Molar pregnancy and risk for cancer in women and their male partners. Am J Obstet Gynecol 181:630–634PubMedCrossRefGoogle Scholar
  122. 122.
    Ordi J, Romagosa C, Tavassoli FA, Nogales F, Palacin A, Condom E, Torne A, Cardesa A (2003) CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors. Am J Surg Pathol 27:178–186PubMedCrossRefGoogle Scholar
  123. 123.
    Palmer JR (1994) Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 39:155–162PubMedGoogle Scholar
  124. 124.
    Palmer JE, Macdonald M, Wells M, Hancock BW, Tidy JA (2008) Epithelioid trophoblastic tumor: a review of the literature. J Reprod Med 53:465–475PubMedGoogle Scholar
  125. 125.
    Papadopoulos AJ, Foskett M, Seckl MJ, McNeish I, Paradinas FJ, Rees H, Newlands ES (2002) Twenty-five years’ clinical experience with placental site trophoblastic tumors. J Reprod Med 47:460–464PubMedGoogle Scholar
  126. 126.
    Parker A, Lee V, Dalrymple C, Valmadre S, Russell P (2003) Epithelioid trophoblastic tumour: report of a case in the fallopian tube. Pathology 35:136–140PubMedGoogle Scholar
  127. 127.
    Patten DK, Lindsay I, Fisher R, Sebire N, Savage PM, Seckl MJ (2008) Gestational choriocarcinoma mimicking a uterine adenocarcinoma. J Clin Oncol 26:5126–5127PubMedCrossRefGoogle Scholar
  128. 128.
    Pfeffer PE, Sebire N, Lindsay I, McIndoe A, Lim A, Seckl MJ (2007) Fertility-sparing partial hysterectomy for placental-site trophoblastic tumour. Lancet Oncol 8:744–746PubMedCrossRefGoogle Scholar
  129. 129.
    Phippen NT, Lowery WJ, Leath CA 3rd, Kost ER (2010) Epithelioid trophoblastic tumor masquerading as invasive squamous cell carcinoma of the cervix after an ectopic pregnancy. Gynecol Oncol 117:387–388PubMedCrossRefGoogle Scholar
  130. 130.
    Piura B (2006) Placental site trophoblastic tumor–a challenging rare entity. Eur J Gynaecol Oncol 27:545–551PubMedGoogle Scholar
  131. 131.
    Piura B, Rabinovich A, Meirovitz M, Shaco-Levy R (2007) Placental site trophoblastic tumor: report of four cases and review of literature. Int J Gynecol Cancer 17:258–262PubMedCrossRefGoogle Scholar
  132. 132.
    Popiolek DA, Yee H, Mittal K, Chiriboga L, Prinz MK, Caragine TA, Budimlija ZM (2006) Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole. Hum Pathol 37:1426–1434PubMedCrossRefGoogle Scholar
  133. 133.
    Randall TC, Coukos G, Wheeler JE, Rubin SC (2000) Prolonged remission of recurrent, metastatic placental site trophoblastic tumor after chemotherapy. Gynecol Oncol 76:115–117PubMedCrossRefGoogle Scholar
  134. 134.
    Redline RW, Hassold T, Zaragoza MV (1998) Prevalence of the partial molar phenotype in triploidy of maternal and paternal origin. Hum Pathol 29:505–511PubMedCrossRefGoogle Scholar
  135. 135.
    Reid A, Heyworth J, de Klerk N, Musk AW (2009) Asbestos exposure and gestational trophoblastic disease: a hypothesis. Cancer Epidemiol Biomarkers Prev 18:2895–2898PubMedCrossRefGoogle Scholar
  136. 136.
    Rinne K, Shahabi S, Cole L (1999) Following metastatic placental site trophoblastic tumor with urine b-core fragment. Gynecol Oncol 74:302–303PubMedCrossRefGoogle Scholar
  137. 137.
    Rodabaugh KJ, Bernstein MR, Goldstein DP, Berkowitz RS (1998) Natural history of postterm choriocarcinoma. J Reprod Med 43:75–80PubMedGoogle Scholar
  138. 138.
    Rotmensch S, Cole LA (2000) False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations. Lancet 355:712–715PubMedCrossRefGoogle Scholar
  139. 139.
    Schmid P, Nagai Y, Agarwal R, Hancock B, Savage PM, Sebire NJ, Lindsay I, Wells M, Fisher RA, Short D et al (2009) Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study. Lancet 374:48–55PubMedCrossRefGoogle Scholar
  140. 140.
    Seckl MJ, Fisher RA, Salerno G, Rees H, Paradinas FJ, Foskett M, Newlands ES (2000) Choriocarcinoma and partial hydatidiform moles. Lancet 356:36–39PubMedCrossRefGoogle Scholar
  141. 141.
    Seki K, Matsui H, Sekiya S (2004) Advances in the clinical laboratory detection of gestational trophoblastic disease. Clin Chim Acta 349:1–13PubMedCrossRefGoogle Scholar
  142. 142.
    Sharkey AM, King A, Clark DE, Burrows TD, Loke YW (1999) Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy. Biol Reprod 60:355–364PubMedCrossRefGoogle Scholar
  143. 143.
    Shih I-M (1999) The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 189:4–11PubMedCrossRefGoogle Scholar
  144. 144.
    Shih I-M (2007) Trophogram, an immunohistochemistry-based algorithmic approach, in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Ann Diagn Pathol 11:228–234PubMedCrossRefGoogle Scholar
  145. 145.
    Shih I-M (2007) Gestational trophoblastic neoplasia—pathogenesis and potential therapeutic targets. Lancet Oncol 8:642–650PubMedCrossRefGoogle Scholar
  146. 146.
    Shih I-M (2009) Gestational trophoblastic lesions. In: Nucci MR, Oliva E (eds) Gynecologic pathology. Churchill Livingstone Elsevier, London, pp 645–665CrossRefGoogle Scholar
  147. 147.
    Shih I-M, Hsu MY, Oldt RJ, Herlyn M, Gearhart JD, Kurman RJ (2002) The role of E-cadherin in the motility and invasion of implantation site intermediate trophoblast. Placenta 23:706–715PubMedGoogle Scholar
  148. 148.
    Shih I-M, Kuo KT (2008) Power of the eternal youth: Nanog expression in the gestational choriocarcinoma. Am J Pathol 173:911–914PubMedCrossRefGoogle Scholar
  149. 149.
    Shih I-M, Kurman RJ (1996) Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab Invest 75:377–388PubMedGoogle Scholar
  150. 150.
    Shih I-M, Kurman RJ (1998) Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 22:1393–1403PubMedCrossRefGoogle Scholar
  151. 151.
    Shih I-M, Kurman RJ (1998) Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies. Hum Pathol 29:27–33PubMedCrossRefGoogle Scholar
  152. 152.
    Shih I-M, Kurman RJ (1999) Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. Int J Gynecol Pathol 18:144–150PubMedCrossRefGoogle Scholar
  153. 153.
    Shih I-M, Kurman RJ (2001) The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol 20:31–47PubMedCrossRefGoogle Scholar
  154. 154.
    Shih I-M, Kurman RJ (2001) Placental site trophoblastic tumor–past as prologue. Gynecol Oncol 82:413–414PubMedCrossRefGoogle Scholar
  155. 155.
    Shih I-M, Kurman RJ (2002) Molecular basis of gestational trophoblastic diseases. Curr Mol Med 2:1–12PubMedCrossRefGoogle Scholar
  156. 156.
    Shih I-M, Kurman RJ (2004) p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol 28:1177–1183PubMedCrossRefGoogle Scholar
  157. 157.
    Shih I-M, Schnaar RL, Gearhart JD, Kurman RJ (1997) Distribution of cells bearing the HNK-1 epitope in the human placenta. Placenta 18:667–674PubMedCrossRefGoogle Scholar
  158. 158.
    Shih I-M, Seidman JD, Kurman RJ (1999) Placental site nodule and characterization of distinctive types of intermediate trophoblast. Hum Pathol 30:687–694PubMedCrossRefGoogle Scholar
  159. 159.
    Silva EG, Tornos C, Lage J, Ordonez NG, Morris M, Kavanagh J (1993) Multiple nodules of intermediate trophoblast following hydatidiform moles. Int J Gynecol Pathol 12:324–332PubMedCrossRefGoogle Scholar
  160. 160.
    Singer G, Kurman RJ, McMaster M, Shih I-M (2002) HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol 26(7):914–920PubMedCrossRefGoogle Scholar
  161. 161.
    Siu MKY, Wong ESY, Chan H-Y, Ngan HYS, Chan KYK, Cheung ANY (2008) Overexpression of Nanog in gestational trophoblastic diseases. Effect on apoptosis, cell invasion and clinical outcome. Am J Pathol 173:1165–1172PubMedCrossRefGoogle Scholar
  162. 162.
    Slim R, Mehio A (2007) The genetics of hydatidiform moles: new lights on an ancient disease. Clin Genet 71:25–34PubMedCrossRefGoogle Scholar
  163. 163.
    Soper JT (2006) Gestational trophoblastic disease. Obstet Gynecol 108:176–187PubMedCrossRefGoogle Scholar
  164. 164.
    Su YN, Cheng WF, Chen CA, Lin TY, Hsieh FJ, Cheng SP, Hsieh CY (1999) Pregnancy with primary tubal placental site trophoblastic tumor–A case report and literature review. Gynecol Oncol 73:322–325PubMedCrossRefGoogle Scholar
  165. 165.
    Suzuki T, Goto S, Nawa A, Kurauchi O, Saito M, Tomoda Y (1993) Identification of the pregnancy responsible for gestational trophoblastic disease by DNA analysis. Obstet Gynecol 82:629–634PubMedGoogle Scholar
  166. 166.
    Swisher E, Drescher CW (1998) Metastatic placental site trophoblastic tumor: long-term remission in a patient treated with EMA/CO chemotherapy. Gynecol Oncol 68:62–65PubMedCrossRefGoogle Scholar
  167. 167.
    Szulman AE, Surti U (1982) The clinicopathologic profile of the partial hydatidiform mole. Obstet Gynecol 59:597–602PubMedGoogle Scholar
  168. 168.
    Tavassoli FA, Devilee P (2003) WHO classification of tumors. In: Pathology and genetics tumors of the breast and female genital organs, IARC Press, Lyon, pp 113–161Google Scholar
  169. 169.
    Trask C, Lage JM, Roberts DJ (1994) A second case of “chorangiocarcinoma” presenting in a term asymptomatic twin pregnancy: choriocarcinoma in situ with associated villous vascular proliferation. Int J Gynecol Pathol 13:87–91PubMedCrossRefGoogle Scholar
  170. 170.
    Tsai HW, Lin CP, Chou CY, Li CF, Chow NH, Shih I-M, Ho CL (2008) Placental site nodule transformed into a malignant epithelioid trophoblastic tumour with pelvic lymph node and lung metastasis. Histopathology 53:601–604PubMedGoogle Scholar
  171. 171.
    Twiggs LB, Hartenbach E, Saltzman AK, King LA (1998) Metastatic placental site trophoblastic tumor. Int J Gynaecol Obstet 60(Suppl 1):S51–S55PubMedCrossRefGoogle Scholar
  172. 172.
    Ueda SM, Mao TL, Kuhajda FP, Vasoontara C, Giuntoli RL, Bristow RE, Kurman RJ, Shih Ie M (2009) Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93. Am J Pathol 175:2618–2624PubMedCrossRefGoogle Scholar
  173. 173.
    Urabe S, Fujiwara H, Miyoshi H, Arihiro K, Soma H, Yoshihama I, Mineo S, Kudo Y (2007) Epithelioid trophoblastic tumor of the lung. J Obstet Gynaecol Res 33:397–401PubMedCrossRefGoogle Scholar
  174. 174.
    Vencken PM, Ewing PC, Zweemer RP (2006) Epithelioid trophoblastic tumour: a case report and review of the literature. J Clin Pathol 59:1307–1308PubMedCrossRefGoogle Scholar
  175. 175.
    Wells M (2007) The pathology of gestational trophoblastic disease: recent advances. Pathology 39:88–96PubMedCrossRefGoogle Scholar
  176. 176.
    Xu ML, Yang B, Carcangiu ML, Hui P (2009) Epithelioid trophoblastic tumor: comparative genomic hybridization and diagnostic DNA genotyping. Mod Pathol 22:232–238PubMedCrossRefGoogle Scholar
  177. 177.
    Xue WC, Guan XY, Ngan HY, Shen DH, Khoo US, Cheung AN (2002) Malignant placental site trophoblastic tumor: a cytogenetic study using comparative genomic hybridization and chromosome in situ hybridization. Cancer 94:2288–2294PubMedCrossRefGoogle Scholar
  178. 178.
    Yap KL, Hafez MJ, Mao TL, Kurman RJ, Murphy KM, Shih Ie M (2010) Lack of a y-chromosomal complement in the majority of gestational trophoblastic neoplasms. J Oncol 2010:364508PubMedCrossRefGoogle Scholar
  179. 179.
    Young RH, Kurman RJ, Scully RE (1990) Placental site nodules and plaques. A clinicopathologic analysis of 20 cases. Am J Surg Pathol 14:1001–1009PubMedCrossRefGoogle Scholar
  180. 180.
    Young RH, Scully RE (1984) Placental-site trophoblastic tumor: current status. Clin Obstet Gynecol 27:248–258PubMedCrossRefGoogle Scholar
  181. 181.
    Young RH, Scully RE, McCluskey RT (1985) A distinctive glomerular lesion complicating placental site trophoblastic tumor: report of two cases. Hum Pathol 16:35–42PubMedCrossRefGoogle Scholar
  182. 182.
    Yuan CC, Wang PH, Ng HT (1999) High hCG level is a risk factor for predicting the occurrence of brain and/or liver metastases from gestational choriocarcinoma. Int J Gynaecol Obstet 65:67–69PubMedCrossRefGoogle Scholar
  183. 183.
    Zalel Y, Dgani R (1997) Gestational trophoblastic disease following the evacuation of partial hydatidiform mole: a review of 66 cases. Eur J Obstet Gynecol Reprod Biol 71:67–71PubMedCrossRefGoogle Scholar
  184. 184.
    Zanetta G, Maggi R, Colombo M, Bratina G, Mangioni C (1997) Choriocarcinoma coexistent with intrauterine pregnancy: two additional cases and a review of the literature. Int J Gynecol Cancer 7:66–77PubMedCrossRefGoogle Scholar
  185. 185.
    Zhang H-J, Xue W-C, Siu M, Liao X-Y, Ngan HY-S, Cheung AN-Y (2009) P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics. Int J Gynecol Pathol 28:172–178PubMedCrossRefGoogle Scholar
  186. 186.
    Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Kdjana E, Wheelock M, Damsky CH (1997) Human cytotrophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion? J Clin Invest 99:2139–2151PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Ie-Ming Shih
    • 1
  • Michael T. Mazur
    • 2
  • Robert J. Kurman
    • 3
  1. 1.Department of Pathology, Division of Gynecologic PathologyJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Pathology Associates of SyracuseSUNY Upstate Medical UniversitySyracuseUSA
  3. 3.Departments of Gynecology, Obstetrics, Pathology and Oncology, Division of Gynecologic PathologyJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations